Provided by Tiger Trade Technology Pte. Ltd.

Information

5.08
+0.11002.21%
Post-market: 5.100.0200+0.39%19:30 EDT
Volume:102.93K
Turnover:515.57K
Market Cap:245.94M
PE:21.18
High:5.09
Open:4.97
Low:4.95
Close:4.97
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.61
T/O Rate:0.29%
Dividend:0.18
Dividend Rate:3.54%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.57
PE(LYR):26.74

Loading ...

ISG Launches Oracle Cloud, Technology Ecosystem Provider Study Ahead of November 2026 Report Series

Reuters
·
Jul 29

Isg to Study Oracle Cloud, Technology Ecosystem Providers

THOMSON REUTERS
·
Jul 29

Quantum X Labs Demonstrated a Complete End-to-End Quantum-Enabled Clinical Data Analysis Use Case by Using Real-World Clinical Information on a Quantum Computer Simulator

GlobeNewswire
·
Jul 29

Zhejiang Huatie Emergency Equipment Faces China Administrative Penalties for Information Disclosure Violations

MT Newswires Live
·
Jul 29

Endesa Publishes First-Half 2026 Financial Information for Investors

TIPRANKS
·
Jul 29

East Money Information Issues 4 Billion Yuan in Short-Term Bonds

MT Newswires Live
·
Jul 29

Information Services Sector Shows Strong Growth, Bolstering Guangdong's Manufacturing-Service Industry Collaboration

Deep News
·
Jul 29

Press Release: EigenQ Appoints Mark Pecen as Vice Chairman and Promotes Alexander Truskovsky to Chief Information Security Officer

Dow Jones
·
Jul 28

Hansoh Pharma's HS-20093 Achieves Primary Goal in Phase III Osteosarcoma Study

Stock News
·
Jul 28

Lianyou Metals Discloses Convertible Bond Information After OTC Notification

MT Newswires Live
·
Jul 28

ISG Says German Enterprises Shift to Software-defined Networks to Support Cloud, AI Workloads

Reuters
·
Jul 28

Hong Kong Stock Movers: LEPU BIO Surges Nearly 4% After Positive Topline Results from Global Phase III CMG901 Trial

Stock News
·
Jul 28

InnoCare Pharma's Phase III Trial of Fadeucravacitinib Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data

TIPRANKS
·
Jul 28

Keymed’s CLDN18.2 Drug CMG901 Delivers Phase III Survival Gain in Gastric Cancer

TIPRANKS
·
Jul 28

3i Group plc (III) Receives a Sell from RBC Capital

TIPRANKS
·
Jul 28

Origin Energy CEO Says Information of Around 900,000 Current, Former Customers Accessed in Data Breach Incident

MT Newswires Live
·
Jul 28

Clinuvel maps SCENESSE’s path in vitiligo with new Phase III trial

TIPRANKS
·
Jul 28

Union Pacific, Norfolk Southern File Supplemental Information to STB on Merger

Dow Jones
·
Jul 28

Jiangsu Lopal Tech Calls EGM to Approve Indonesia Phase III Expansion

TIPRANKS
·
Jul 27